This triple mechanism produces the most dramatic weight loss seen in clinical trials, with some participants losing up to 24% of body weight
Other concerning symptoms include: Signs of dehydration (decreased urination, dizziness, extreme thirst) Persistent diarrhea lasting more than 48 hours Blood in stool or vomit Unexplained weight loss beyond expected therapeutic effects Severe constipation unresponsive to standard measures New or worsening heartburn or reflux symptoms Symptoms of gallbladder disease (right upper abdominal pain, especially after meals, fever, or jaundice) Signs of possible bowel obstruction or ileus (severe abdominal distension, inability to pass gas or stool) Before starting digestive enzyme supplements or any over-the-counter products, patients should discuss this decision with their healthcare provider or pharmacist
Eine abwechslungsreiche Ernhrung ist stets ein guter Weg, um den Krper mit allen essenziellen Stoffen zu versorgen
How We Reviewed: We did not test the product
The SOUL trial included 9650 participants (randomized 1:1 to oral semaglutide or placebo), of whom 2596 (26.9%) were using SGLT2i at baseline and 4718 (48.9%) had any SGLT2i use during the trial
The documented protocol starts at 2.5 mg once weekly as a tolerability dose, then titrates up roughly every four weeks 5, 7.5, 10, 12.5, up to a 15 mg maximum maintenance dose
